• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

卡博替尼继发的获得性反应性穿通性胶原病：一例报告及文献复习

Acquired reactive perforating collagenosis secondary to Cabozantinib: A case report and literature review.

作者信息

Rehan Zahra, Haner Andrea, Taleb Amina, Ikeri Nzechukwu, Hardin Jori

机构信息

Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

The Jack Ady Cancer Centre, Lethbridge, AB, Canada.

出版信息

SAGE Open Med Case Rep. 2024 Dec 16;12:2050313X241304961. doi: 10.1177/2050313X241304961. eCollection 2024.

DOI:10.1177/2050313X241304961
PMID:39691349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11650492/
Abstract

Acquired perforating dermatoses (APD) encompass a group of skin conditions distinguished by transepidermal elimination of dermal components. Acquired reactive perforating collagenosis (ARPC), a subtype of APD, has been reported most commonly in association with diabetes mellitus, chronic renal failure, and medications. In this report, we identify a novel case of ARPC secondary to Cabozantinib treatment.

摘要

获得性穿通性皮肤病（APD）是一组以真皮成分经表皮排出为特征的皮肤疾病。获得性反应性穿通性胶原病（ARPC）是APD的一种亚型，最常报道与糖尿病、慢性肾衰竭及药物有关。在本报告中，我们发现了一例继发于卡博替尼治疗的ARPC新病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/11650492/b586f975ad83/10.1177_2050313X241304961-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/11650492/20010f0a0db1/10.1177_2050313X241304961-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/11650492/cbefce035e54/10.1177_2050313X241304961-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/11650492/b586f975ad83/10.1177_2050313X241304961-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/11650492/20010f0a0db1/10.1177_2050313X241304961-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/11650492/cbefce035e54/10.1177_2050313X241304961-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a3b/11650492/b586f975ad83/10.1177_2050313X241304961-fig3.jpg

相似文献

1
Acquired reactive perforating collagenosis secondary to Cabozantinib: A case report and literature review.卡博替尼继发的获得性反应性穿通性胶原病：一例报告及文献复习
SAGE Open Med Case Rep. 2024 Dec 16;12:2050313X241304961. doi: 10.1177/2050313X241304961. eCollection 2024.
2
Unusual eruption in association with sorafenib: a case of acquired perforating dermatosis, reactive perforating collagenosis type.与索拉非尼相关的罕见皮疹：一例获得性穿通性皮肤病，反应性穿通性胶原病型。
Dermatol Online J. 2018 Dec 15;24(12):13030/qt8b40k5kg.
3
[Acquired perforating dermatosis in the patient with chronic kidney disease – case report and literature review].[慢性肾脏病患者获得性穿通性皮肤病——病例报告及文献复习]
Przegl Lek. 2016;73(9):680-3.
4
Acquired perforating dermatosis: clinicopathological features in twenty-two cases.获得性穿通性皮肤病：22例临床病理特征
J Eur Acad Dermatol Venereol. 2006 Jul;20(6):679-88. doi: 10.1111/j.1468-3083.2006.01571.x.
5
A clinicopathologic study of thirty cases of acquired perforating dermatosis in Korea.韩国30例获得性穿通性皮肤病的临床病理研究。
Ann Dermatol. 2014 Apr;26(2):162-71. doi: 10.5021/ad.2014.26.2.162. Epub 2014 Apr 30.
6
Acquired Reactive Perforating Collagenosis: Case Series.获得性反应性穿通性胶原病：病例系列
Indian Dermatol Online J. 2022 Dec 29;14(1):72-76. doi: 10.4103/idoj.idoj_373_22. eCollection 2023 Jan-Feb.
7
Acquired reactive perforating collagenosis in a patient with lung fibrosis.一名肺纤维化患者的获得性反应性穿通性胶原病
J Dermatol. 2004 Nov;31(11):916-9. doi: 10.1111/j.1346-8138.2004.tb00626.x.
8
Kyrle disease and acquired perforating collagenosis secondary to chronic renal failure and diabetes mellitus.Kyrle病以及继发于慢性肾衰竭和糖尿病的获得性穿通性胶原病。
Case Rep Dermatol. 2011 Sep;3(3):209-11. doi: 10.1159/000333005. Epub 2011 Sep 29.
9
Acquired perforating dermatosis in a patient with chronic renal failure.一名慢性肾衰竭患者的获得性穿通性皮肤病。
An Bras Dermatol. 2016 Sep-Oct;91(5 suppl 1):10-13. doi: 10.1590/abd1806-4841.20164619.
10
Expression of the 67-kDa elastin receptor in perforating skin disorders.67-kDa弹性蛋白受体在穿通性皮肤病中的表达。
Br J Dermatol. 2002 Jan;146(1):74-9. doi: 10.1046/j.1365-2133.2002.04550.x.

本文引用的文献

1
Successful treatment with phototherapy for acquired reactive perforating collagenosis subsequently exacerbated following improvement of diffuse erythema induced by immune checkpoint inhibitors.光疗成功治疗获得性反应性穿通性胶原病后，免疫检查点抑制剂诱导的弥漫性红斑改善，病情随后加重。
J Dermatol. 2023 May;50(5):e164-e165. doi: 10.1111/1346-8138.16694. Epub 2022 Dec 30.
2
Acquired perforating dermatosis induced by necitumumab.西妥昔单抗诱发的获得性穿通性皮肤病
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e822-e823. doi: 10.1111/jdv.18306. Epub 2022 Jun 17.
3
Acquired Perforating Dermatosis Induced by PD-1 Inhibitor: A Case Report.
获得性穿通性皮肤病由 PD-1 抑制剂诱导：一例报告。
Am J Dermatopathol. 2021 Dec 1;43(12):942-944. doi: 10.1097/DAD.0000000000002026.
4
Erlotinib-induced reactive perforating collagenosis in a case of lung adenocarcinoma.厄洛替尼诱发的反应性穿通性胶原病一例肺腺癌患者
Indian J Dermatol Venereol Leprol. 2021;87(4):548-551. doi: 10.25259/IJDVL_288_20.
5
Natalizumab-induced acquired perforating dermatosis.那他珠单抗诱发的获得性穿通性皮肤病。
Clin Exp Dermatol. 2021 Oct;46(7):1373-1375. doi: 10.1111/ced.14699. Epub 2021 Jun 4.
6
Case of acquired reactive perforating collagenosis induced by panitumumab for colon cancer.帕尼单抗诱发的结肠癌获得性反应性穿通性胶原病病例
J Dermatol. 2021 Feb;48(2):e114-e115. doi: 10.1111/1346-8138.15718. Epub 2020 Dec 2.
7
Reactive perforating collagenosis: a rare side effect associated with sorafenib.反应性穿透性胶原病：与索拉非尼相关的罕见副作用。
Rev Esp Enferm Dig. 2020 Dec;112(12):960-961. doi: 10.17235/reed.2020.7138/2020.
8
Acquired reactive perforating collagenosis: A case report and review of the literature.获得性反应性穿通性胶原病：一例报告及文献复习
Medicine (Baltimore). 2020 May 29;99(22):e20391. doi: 10.1097/MD.0000000000020391.
9
Rare case of acquired perforating dermatosis induced by cetuximab.西妥昔单抗诱发获得性穿通性皮肤病的罕见病例。
J Dermatol. 2020 Jan;47(1):e11-e12. doi: 10.1111/1346-8138.15098. Epub 2019 Sep 20.
10
Unusual eruption in association with sorafenib: a case of acquired perforating dermatosis, reactive perforating collagenosis type.与索拉非尼相关的罕见皮疹：一例获得性穿通性皮肤病，反应性穿通性胶原病型。
Dermatol Online J. 2018 Dec 15;24(12):13030/qt8b40k5kg.